ÂÜÀòÂÒÂ×

Sarah MacInnes has a diverse work experience, starting with their current position as a Senior Scientist at RAPT Therapeutics, which they started in June 2022. Prior to this, they worked at Bristol Myers Squibb (formerly MyoKardia) as a Senior Scientist from July 2021 to June 2022 and as a Scientist II from September 2014 to June 2022. Before joining Bristol Myers Squibb, Sarah was employed as a Research Scientist at MyoKardia from an unspecified date to June 2022.

Sarah also gained experience as a Volunteer at The Tech Museum of Innovation from 2012 to 2014. Sarah then worked as a Postdoctoral Fellow at Merck from an unspecified date to 2012 and at DNAX Research Institute from an unspecified date to 2012. Prior to their postdoctoral positions, Sarah was a PhD Student at the Institute of Cardiovascular Sciences from 2004 to 2009.

Sarah MacInnes completed their education at the University of Manitoba, where they obtained a Master of Science degree in Physiology. Following this, they pursued a PhD in the same field at the University of Manitoba. Upon completion of their doctoral studies, they proceeded to Stanford University where they undertook a Postdoctoral Fellowship specializing in Cardiovascular Science. Sarah's education history spans from their studies at the University of Manitoba to their tenure as a Postdoctoral Fellow at Stanford University, concluding in 2014.